ArticleJournal of medicinal chemistry2021

Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization.

Jean-Olivier Zirimwabagabo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.